Preclinical Study by Acorda Therapeutics Shows Efficacy of Chondroitinase in Repairing Spinal Cord After Traumatic Injury > Morton Cure Paralysis Fund

Research Links

Our staff has deemed the following public research links as significant and/or new findings by the global research community in the search for a cure for paralysis. You can search the database by category, keyword, name, and/or date. Keep abreast of cure research breakthroughs by signing up for our monthly research newsletter.

Please note that the research posted here is not affiliated with the MCPF unless that is specifically stated.

Preclinical Study by Acorda Therapeutics Shows Efficacy of Chondroitinase in Repairing Spinal Cord After Traumatic Injury

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Feb. 23, 2005--Results of a preclinical study from Acorda Therapeutics showed chondroitinase was effective in improving recovery after spinal cord injury. This advance was reported today in the Journal of Neurotrauma.

In the study, rats were treated with either chondroitinase or a control following a spinal cord injury, and evaluated over 10 weeks of recovery. Animals treated with chondroitinase showed significant improvements in motor function of the limbs and bladder function compared to those treated with a control (ineffective) enzyme.

Chondroitinase ABCI was used to treat rats with a contusion, or crush, injury of the spinal cord. Since only a small percentage of human spinal cord injuries involve a complete severing of the spinal cord, the contusion ...

http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050223005543&newsLang=en

posted @ Wednesday, February 23, 2005 12:00 AM by host